Literature DB >> 2396928

Neurologic disease in human immunodeficiency virus-infected drug abusers.

R Malouf1, G Jacquette, J Dobkin, J C Brust.   

Abstract

Previous studies of human immuno-deficiency virus-related neurologic disease have been either retrospective or have included mostly homosexual patients. We sought to determine (1) the true prevalence of neurologic abnormalities in patients with acquired immunodeficiency syndrome or lymphadenopathy acquired immunodeficiency-related complex, and (2) whether differences in prevalence or type of neurological abnormality exist between parenteral drug abusers and non-parenteral drug abusers. We prospectively evaluated 190 adult inpatients with either acquired immunodeficiency syndrome (129) or lymphadenopathy acquired immunodeficiency-related complex (61); 151 (80%) were parenteral drug abusers, and 172 patients (91%) had neurologic symptoms or signs. There was no significant difference in prevalence of neurologic disease between parenteral drug abusers and non-parenteral drug abusers, or between patients with acquired immunodeficiency syndrome and those with lymphadenopathy acquired immunodeficiency-related complex. The prevalence of neurologic symptoms in these patients with lymphadenopathy acquired immunodeficiency-related complex and acquired immunodeficiency syndrome is the highest reported to date and appears to reflect the prospective nature of the study.

Entities:  

Mesh:

Year:  1990        PMID: 2396928     DOI: 10.1001/archneur.1990.00530090076016

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  2 in total

1.  The neuropsychological consequences of HIV infection in drug addicts.

Authors:  S F Cappa; T M Truong; D Vangi; L A Vignolo
Journal:  Ital J Neurol Sci       Date:  1992-09

2.  HIV-specific changes in the motor performance of HIV-positive intravenous drug abusers.

Authors:  H J von Giesen; H Hefter; H Roick; S Mauss; G Arendt
Journal:  J Neurol       Date:  1994-12       Impact factor: 4.849

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.